Table 7.
Eligibility criteria for biopsy of primary and liver metastases.
| Study characteristic | Inclusion criteria | Exclusion criteria |
| Patient population | Patients with primary neuroendocrine tumors and/or NET liver metastases | Children or adolescents (under the age of 18 years old) |
| Patients who underwent a biopsy of the primary and liver metastasis |
|
|
| Patients who underwent multiple biopsies of the liver metastases and/or healthy parenchyma | ||
| Test of interest | Biopsy of primary NET and/or NET liver metastases | Studies that do not report histo-pathological biopsy results |
| Study design | Randomized controlled trials (RCTs) | Case reports |
| Prospective and retrospective comparative cohort studies | ||
| Noncomparative cohort studies | Case-control studies |
Reviews |
| Case series | ||
| Cross-sectional and/or cohort studies |